FDA cites Mark Cuban’s drug compounding center in Dallas with sterility, quality concerns

The FDA is rais­ing steril­i­ty and oth­er qual­i­ty con­cerns with Mark Cuban’s Cost Plus Drugs com­pound­ing fa­cil­i­ty in Dal­las, fol­low­ing a nine-day in­spec­tion of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.